Alomone Labs

Executive Summary

Alomone Labs is a privately held Israeli biotechnology company that has been a leading supplier of high-quality research reagents for membrane proteins for over 35 years. Specializing in ion channels, GPCRs, transporters, and neurotrophic factors, the company offers a comprehensive portfolio of antibodies, toxins, modulators, and research kits. Its products are widely used in academic and industrial laboratories for neuroscience, cardiovascular, oncology, immunology, and metabolism research. With expertise in toxin isolation, recombinant peptide synthesis, and polyclonal antibody generation, Alomone Labs has established a strong reputation for reliability and innovation in the life science tools market. The company serves a global customer base and continues to expand its product offerings through internal R&D and strategic collaborations.

Upcoming Catalysts (preview)

• Q2 2026Launch of new recombinant toxin panel for pain research90% success
• Q4 2026Expansion into CRISPR-based functional assay kits using existing antibodies70% success
• H1 2027Strategic partnership with a major pharmaceutical company for ion channel screening services60% success